Showing results (51-60 of 124) with videos related to
Sort By:
Pageof 13
British Journal of Clinical Pharmacology|June 2, 2021
Test-dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non-malignant disordersSharat Chandra, Kana Mizuno, Junfang Zhao, et al.Clinical Immunology (Orlando, Fla.)|April 29, 2009
Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populationsRebecca A Marsh, Joyce Villanueva, Mi-Ok Kim, et al.Cell Death & Disease|October 21, 2022
Epstein Barr virus-mediated transformation of B cells from XIAP-deficient patients leads to increased expression of the tumor suppressor CADM1Christine Engelmann, Patrick Schuhmachers, Hana Zdimerova, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 22, 2017
Incidence and Outcomes of Central Nervous System Hemophagocytic Lymphohistiocytosis Relapse after Reduced-Intensity Conditioning Hematopoietic Stem Cell TransplantationDana T Lounder, Pooja Khandelwal, Sharat Chandra, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2016
Cytokine Profile of Engraftment Syndrome in Pediatric Hematopoietic Stem Cell Transplant RecipientsPooja Khandelwal, Sabine Mellor-Heineke, Najibah Rehman, et al.The Journal of Allergy and Clinical Immunology. in Practice|April 5, 2025
Expert-Based, Institutional Approaches for Reducing the Diagnostic Odyssey of Patients With Inborn Errors of ImmunityNicholas L Rider, Lisa Bastarache, John T Anderson, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 8, 2016
A Pharmacokinetic and Pharmacodynamic Study of Maraviroc as Acute Graft-versus-Host Disease Prophylaxis in Pediatric Allogeneic Stem Cell Transplant Recipients with Nonmalignant DiagnosesPooja Khandelwal, Tsuyoshi Fukuda, Kana Mizuno, et al.The Journal of Allergy and Clinical Immunology|July 6, 2022
Excessive IL-10 and IL-18 trigger hemophagocytic lymphohistiocytosis-like hyperinflammation and enhanced myelopoiesisYuting Tang, Qian Xu, Hui Luo, et al.Blood Advances|November 10, 2025
Novel CSF Biomarkers for facilitating diagnosis of CNS-HLH from other Neuroinflammatory DisordersSharat Chandra, Kenneth D Greis, Somchai Chutipongtanate, et al.Journal of Clinical Immunology|May 25, 2020
Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic MicroangiopathyNicholas J Gloude, Christopher E Dandoy, Stella M Davies, et al.Pageof 13